Combined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Urgent Isolated CABG Using MiECC in Patients With Recent Acute Myocardial Infarction

Combined Use of a Novel Cardioplegic Formula With MPS® Versus Cardioplexol ® in Urgent Isolated CABG Using MiECC in Patients With Recent Acute Myocardial Infarction

The goal of this study is to compare the two cardioplegia solutions (blood cardioplegia by means of MPS ® vs. Cardioplexol ®) regarding perioperative outcome and with special attention to cardiac markers in patients with a recent heart attack.

Inclusion Criteria:

• Patients who underwent a CABG using MPS® or Cardioplexol ®
• Heart attack less than 7 days before surgery

Exclusion Criteria:

• use of other cardioplegia solution than Cardioplexol ® or MPS®
• other inventions than CABG
• explicit will of the patient that his data may not be used
• denied general consent